Moreover, treatment with a neutralizing antibody against BGN attenuated the CAF-induced increase in ESCC cell migration, indicating that CAF-derived BGN promotes ESCC cell migration (Figure 1I). Here, BGN is linked to esophageal squamous cell carcinoma.